Ad
related to: lumen metab pro x plus
Search results
Results from the WOW.Com Content Network
Lumen is a health and wellness technology company founded in 2018 by twin sisters Merav and Michal Mor. [3] The company specializes in providing personalized nutrition insights through a handheld device that measures metabolism via breath analysis. Lumen's headquarters are located in Tel Aviv, with additional offices in New York and London. The ...
Lysosomal Pro-Xaa carboxypeptidase (EC 3.4.16.2, angiotensinase C, lysosomal carboxypeptidase C, peptidylprolylamino acid carboxypeptidase, aminoacylproline carboxypeptidase, prolyl carboxypeptidase, carboxypeptidase P, proline-specific carboxypeptidase P, PCP) is an enzyme. [1] [2] This enzyme catalyses the following chemical reaction
Metab-L is an electronic mailing list on inborn errors of metabolism (IEM) that has acquired notability among specialists in that field of medicine, especially from the area of pediatrics. The non-commercial, international, English-language list is a basis of specialist exchange and cooperation with an emphasis on promoting an "IEM community".
The medication has also been found to interact very weakly with the estrogen and progesterone receptors, and to act as an agonist of the pregnane X receptor. Likely due to increased activation of the estrogen and/or progesterone receptors, spironolactone has very weak but significant antigonadotropic effects. [13] [14]
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data ...
This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.
Cefpodoxime is an oral, third-generation cephalosporin antibiotic available in various generic preparations. It is active against both Gram-positive and Gram-negative organisms with notable exceptions including Pseudomonas aeruginosa, Enterococcus, and Bacteroides fragilis.
Established in 1972, Drug Metabolism Reviews is an academic journal that publishes review articles on all aspects of drug metabolism research. It is the official journal of the International Society for the Study of Xenobiotics (ISSX).
Ad
related to: lumen metab pro x plus